The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Pediatric Respiratory Disease Therapeutics Market Research Report 2025
Synopsis
The global Pediatric Respiratory Disease Therapeutics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Pediatric Respiratory Disease Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pediatric Respiratory Disease Therapeutics.
Report Scope
The Pediatric Respiratory Disease Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pediatric Respiratory Disease Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pediatric Respiratory Disease Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis AG
Bayer AG
GSK
Merck
Boehringer Ingelheim
Regeneron Pharmaceuticals
AstraZeneca
Roche
Segment by Type
Anti-Inflammatory Drugs
Bronchodilators
Combination Drugs
Corticosteroid
Monoclonal Antibodies
Others
Segment by Application
Asthma
Cystic Fibrosis
Bronchiolitis
Pneumonia
Idiopathic Pulmonary Fibrosis
Tuberculosis
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pediatric Respiratory Disease Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Pediatric Respiratory Disease Therapeutics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Pediatric Respiratory Disease Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pediatric Respiratory Disease Therapeutics.
Report Scope
The Pediatric Respiratory Disease Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pediatric Respiratory Disease Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pediatric Respiratory Disease Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis AG
Bayer AG
GSK
Merck
Boehringer Ingelheim
Regeneron Pharmaceuticals
AstraZeneca
Roche
Segment by Type
Anti-Inflammatory Drugs
Bronchodilators
Combination Drugs
Corticosteroid
Monoclonal Antibodies
Others
Segment by Application
Asthma
Cystic Fibrosis
Bronchiolitis
Pneumonia
Idiopathic Pulmonary Fibrosis
Tuberculosis
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pediatric Respiratory Disease Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pediatric Respiratory Disease Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Anti-Inflammatory Drugs
1.2.3 Bronchodilators
1.2.4 Combination Drugs
1.2.5 Corticosteroid
1.2.6 Monoclonal Antibodies
1.2.7 Others
1.3 Market by Application
1.3.1 Global Pediatric Respiratory Disease Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Asthma
1.3.3 Cystic Fibrosis
1.3.4 Bronchiolitis
1.3.5 Pneumonia
1.3.6 Idiopathic Pulmonary Fibrosis
1.3.7 Tuberculosis
1.3.8 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pediatric Respiratory Disease Therapeutics Market Perspective (2019-2030)
2.2 Pediatric Respiratory Disease Therapeutics Growth Trends by Region
2.2.1 Global Pediatric Respiratory Disease Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Pediatric Respiratory Disease Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Pediatric Respiratory Disease Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Pediatric Respiratory Disease Therapeutics Market Dynamics
2.3.1 Pediatric Respiratory Disease Therapeutics Industry Trends
2.3.2 Pediatric Respiratory Disease Therapeutics Market Drivers
2.3.3 Pediatric Respiratory Disease Therapeutics Market Challenges
2.3.4 Pediatric Respiratory Disease Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pediatric Respiratory Disease Therapeutics Players by Revenue
3.1.1 Global Top Pediatric Respiratory Disease Therapeutics Players by Revenue (2019-2024)
3.1.2 Global Pediatric Respiratory Disease Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Pediatric Respiratory Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pediatric Respiratory Disease Therapeutics Revenue
3.4 Global Pediatric Respiratory Disease Therapeutics Market Concentration Ratio
3.4.1 Global Pediatric Respiratory Disease Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pediatric Respiratory Disease Therapeutics Revenue in 2023
3.5 Pediatric Respiratory Disease Therapeutics Key Players Head office and Area Served
3.6 Key Players Pediatric Respiratory Disease Therapeutics Product Solution and Service
3.7 Date of Enter into Pediatric Respiratory Disease Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pediatric Respiratory Disease Therapeutics Breakdown Data by Type
4.1 Global Pediatric Respiratory Disease Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Pediatric Respiratory Disease Therapeutics Forecasted Market Size by Type (2025-2030)
5 Pediatric Respiratory Disease Therapeutics Breakdown Data by Application
5.1 Global Pediatric Respiratory Disease Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Pediatric Respiratory Disease Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Pediatric Respiratory Disease Therapeutics Market Size (2019-2030)
6.2 North America Pediatric Respiratory Disease Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Pediatric Respiratory Disease Therapeutics Market Size by Country (2019-2024)
6.4 North America Pediatric Respiratory Disease Therapeutics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pediatric Respiratory Disease Therapeutics Market Size (2019-2030)
7.2 Europe Pediatric Respiratory Disease Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Pediatric Respiratory Disease Therapeutics Market Size by Country (2019-2024)
7.4 Europe Pediatric Respiratory Disease Therapeutics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pediatric Respiratory Disease Therapeutics Market Size (2019-2030)
8.2 Asia-Pacific Pediatric Respiratory Disease Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Pediatric Respiratory Disease Therapeutics Market Size by Region (2019-2024)
8.4 Asia-Pacific Pediatric Respiratory Disease Therapeutics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pediatric Respiratory Disease Therapeutics Market Size (2019-2030)
9.2 Latin America Pediatric Respiratory Disease Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Pediatric Respiratory Disease Therapeutics Market Size by Country (2019-2024)
9.4 Latin America Pediatric Respiratory Disease Therapeutics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pediatric Respiratory Disease Therapeutics Market Size (2019-2030)
10.2 Middle East & Africa Pediatric Respiratory Disease Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Pediatric Respiratory Disease Therapeutics Market Size by Country (2019-2024)
10.4 Middle East & Africa Pediatric Respiratory Disease Therapeutics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis AG
11.1.1 Novartis AG Company Detail
11.1.2 Novartis AG Business Overview
11.1.3 Novartis AG Pediatric Respiratory Disease Therapeutics Introduction
11.1.4 Novartis AG Revenue in Pediatric Respiratory Disease Therapeutics Business (2019-2024)
11.1.5 Novartis AG Recent Development
11.2 Bayer AG
11.2.1 Bayer AG Company Detail
11.2.2 Bayer AG Business Overview
11.2.3 Bayer AG Pediatric Respiratory Disease Therapeutics Introduction
11.2.4 Bayer AG Revenue in Pediatric Respiratory Disease Therapeutics Business (2019-2024)
11.2.5 Bayer AG Recent Development
11.3 GSK
11.3.1 GSK Company Detail
11.3.2 GSK Business Overview
11.3.3 GSK Pediatric Respiratory Disease Therapeutics Introduction
11.3.4 GSK Revenue in Pediatric Respiratory Disease Therapeutics Business (2019-2024)
11.3.5 GSK Recent Development
11.4 Merck
11.4.1 Merck Company Detail
11.4.2 Merck Business Overview
11.4.3 Merck Pediatric Respiratory Disease Therapeutics Introduction
11.4.4 Merck Revenue in Pediatric Respiratory Disease Therapeutics Business (2019-2024)
11.4.5 Merck Recent Development
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Detail
11.5.2 Boehringer Ingelheim Business Overview
11.5.3 Boehringer Ingelheim Pediatric Respiratory Disease Therapeutics Introduction
11.5.4 Boehringer Ingelheim Revenue in Pediatric Respiratory Disease Therapeutics Business (2019-2024)
11.5.5 Boehringer Ingelheim Recent Development
11.6 Regeneron Pharmaceuticals
11.6.1 Regeneron Pharmaceuticals Company Detail
11.6.2 Regeneron Pharmaceuticals Business Overview
11.6.3 Regeneron Pharmaceuticals Pediatric Respiratory Disease Therapeutics Introduction
11.6.4 Regeneron Pharmaceuticals Revenue in Pediatric Respiratory Disease Therapeutics Business (2019-2024)
11.6.5 Regeneron Pharmaceuticals Recent Development
11.7 AstraZeneca
11.7.1 AstraZeneca Company Detail
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca Pediatric Respiratory Disease Therapeutics Introduction
11.7.4 AstraZeneca Revenue in Pediatric Respiratory Disease Therapeutics Business (2019-2024)
11.7.5 AstraZeneca Recent Development
11.8 Roche
11.8.1 Roche Company Detail
11.8.2 Roche Business Overview
11.8.3 Roche Pediatric Respiratory Disease Therapeutics Introduction
11.8.4 Roche Revenue in Pediatric Respiratory Disease Therapeutics Business (2019-2024)
11.8.5 Roche Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Pediatric Respiratory Disease Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Anti-Inflammatory Drugs
Table 3. Key Players of Bronchodilators
Table 4. Key Players of Combination Drugs
Table 5. Key Players of Corticosteroid
Table 6. Key Players of Monoclonal Antibodies
Table 7. Key Players of Others
Table 8. Global Pediatric Respiratory Disease Therapeutics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Pediatric Respiratory Disease Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 10. Global Pediatric Respiratory Disease Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 11. Global Pediatric Respiratory Disease Therapeutics Market Share by Region (2019-2024)
Table 12. Global Pediatric Respiratory Disease Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 13. Global Pediatric Respiratory Disease Therapeutics Market Share by Region (2025-2030)
Table 14. Pediatric Respiratory Disease Therapeutics Market Trends
Table 15. Pediatric Respiratory Disease Therapeutics Market Drivers
Table 16. Pediatric Respiratory Disease Therapeutics Market Challenges
Table 17. Pediatric Respiratory Disease Therapeutics Market Restraints
Table 18. Global Pediatric Respiratory Disease Therapeutics Revenue by Players (2019-2024) & (US$ Million)
Table 19. Global Pediatric Respiratory Disease Therapeutics Market Share by Players (2019-2024)
Table 20. Global Top Pediatric Respiratory Disease Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Respiratory Disease Therapeutics as of 2023)
Table 21. Ranking of Global Top Pediatric Respiratory Disease Therapeutics Companies by Revenue (US$ Million) in 2023
Table 22. Global 5 Largest Players Market Share by Pediatric Respiratory Disease Therapeutics Revenue (CR5 and HHI) & (2019-2024)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Pediatric Respiratory Disease Therapeutics Product Solution and Service
Table 25. Date of Enter into Pediatric Respiratory Disease Therapeutics Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Pediatric Respiratory Disease Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 28. Global Pediatric Respiratory Disease Therapeutics Revenue Market Share by Type (2019-2024)
Table 29. Global Pediatric Respiratory Disease Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 30. Global Pediatric Respiratory Disease Therapeutics Revenue Market Share by Type (2025-2030)
Table 31. Global Pediatric Respiratory Disease Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 32. Global Pediatric Respiratory Disease Therapeutics Revenue Market Share by Application (2019-2024)
Table 33. Global Pediatric Respiratory Disease Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 34. Global Pediatric Respiratory Disease Therapeutics Revenue Market Share by Application (2025-2030)
Table 35. North America Pediatric Respiratory Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. North America Pediatric Respiratory Disease Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 37. North America Pediatric Respiratory Disease Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 38. Europe Pediatric Respiratory Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 39. Europe Pediatric Respiratory Disease Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 40. Europe Pediatric Respiratory Disease Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 41. Asia-Pacific Pediatric Respiratory Disease Therapeutics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 42. Asia-Pacific Pediatric Respiratory Disease Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 43. Asia-Pacific Pediatric Respiratory Disease Therapeutics Market Size by Region (2025-2030) & (US$ Million)
Table 44. Latin America Pediatric Respiratory Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Latin America Pediatric Respiratory Disease Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 46. Latin America Pediatric Respiratory Disease Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 47. Middle East & Africa Pediatric Respiratory Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 48. Middle East & Africa Pediatric Respiratory Disease Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Pediatric Respiratory Disease Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 50. Novartis AG Company Detail
Table 51. Novartis AG Business Overview
Table 52. Novartis AG Pediatric Respiratory Disease Therapeutics Product
Table 53. Novartis AG Revenue in Pediatric Respiratory Disease Therapeutics Business (2019-2024) & (US$ Million)
Table 54. Novartis AG Recent Development
Table 55. Bayer AG Company Detail
Table 56. Bayer AG Business Overview
Table 57. Bayer AG Pediatric Respiratory Disease Therapeutics Product
Table 58. Bayer AG Revenue in Pediatric Respiratory Disease Therapeutics Business (2019-2024) & (US$ Million)
Table 59. Bayer AG Recent Development
Table 60. GSK Company Detail
Table 61. GSK Business Overview
Table 62. GSK Pediatric Respiratory Disease Therapeutics Product
Table 63. GSK Revenue in Pediatric Respiratory Disease Therapeutics Business (2019-2024) & (US$ Million)
Table 64. GSK Recent Development
Table 65. Merck Company Detail
Table 66. Merck Business Overview
Table 67. Merck Pediatric Respiratory Disease Therapeutics Product
Table 68. Merck Revenue in Pediatric Respiratory Disease Therapeutics Business (2019-2024) & (US$ Million)
Table 69. Merck Recent Development
Table 70. Boehringer Ingelheim Company Detail
Table 71. Boehringer Ingelheim Business Overview
Table 72. Boehringer Ingelheim Pediatric Respiratory Disease Therapeutics Product
Table 73. Boehringer Ingelheim Revenue in Pediatric Respiratory Disease Therapeutics Business (2019-2024) & (US$ Million)
Table 74. Boehringer Ingelheim Recent Development
Table 75. Regeneron Pharmaceuticals Company Detail
Table 76. Regeneron Pharmaceuticals Business Overview
Table 77. Regeneron Pharmaceuticals Pediatric Respiratory Disease Therapeutics Product
Table 78. Regeneron Pharmaceuticals Revenue in Pediatric Respiratory Disease Therapeutics Business (2019-2024) & (US$ Million)
Table 79. Regeneron Pharmaceuticals Recent Development
Table 80. AstraZeneca Company Detail
Table 81. AstraZeneca Business Overview
Table 82. AstraZeneca Pediatric Respiratory Disease Therapeutics Product
Table 83. AstraZeneca Revenue in Pediatric Respiratory Disease Therapeutics Business (2019-2024) & (US$ Million)
Table 84. AstraZeneca Recent Development
Table 85. Roche Company Detail
Table 86. Roche Business Overview
Table 87. Roche Pediatric Respiratory Disease Therapeutics Product
Table 88. Roche Revenue in Pediatric Respiratory Disease Therapeutics Business (2019-2024) & (US$ Million)
Table 89. Roche Recent Development
Table 90. Research Programs/Design for This Report
Table 91. Key Data Information from Secondary Sources
Table 92. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pediatric Respiratory Disease Therapeutics Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Pediatric Respiratory Disease Therapeutics Market Share by Type: 2023 VS 2030
Figure 3. Anti-Inflammatory Drugs Features
Figure 4. Bronchodilators Features
Figure 5. Combination Drugs Features
Figure 6. Corticosteroid Features
Figure 7. Monoclonal Antibodies Features
Figure 8. Others Features
Figure 9. Global Pediatric Respiratory Disease Therapeutics Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 10. Global Pediatric Respiratory Disease Therapeutics Market Share by Application: 2023 VS 2030
Figure 11. Asthma Case Studies
Figure 12. Cystic Fibrosis Case Studies
Figure 13. Bronchiolitis Case Studies
Figure 14. Pneumonia Case Studies
Figure 15. Idiopathic Pulmonary Fibrosis Case Studies
Figure 16. Tuberculosis Case Studies
Figure 17. Others Case Studies
Figure 18. Pediatric Respiratory Disease Therapeutics Report Years Considered
Figure 19. Global Pediatric Respiratory Disease Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 20. Global Pediatric Respiratory Disease Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 21. Global Pediatric Respiratory Disease Therapeutics Market Share by Region: 2023 VS 2030
Figure 22. Global Pediatric Respiratory Disease Therapeutics Market Share by Players in 2023
Figure 23. Global Top Pediatric Respiratory Disease Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Respiratory Disease Therapeutics as of 2023)
Figure 24. The Top 10 and 5 Players Market Share by Pediatric Respiratory Disease Therapeutics Revenue in 2023
Figure 25. North America Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. North America Pediatric Respiratory Disease Therapeutics Market Share by Country (2019-2030)
Figure 27. United States Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Canada Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Europe Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Europe Pediatric Respiratory Disease Therapeutics Market Share by Country (2019-2030)
Figure 31. Germany Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. France Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. U.K. Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Italy Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Russia Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Nordic Countries Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Asia-Pacific Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Asia-Pacific Pediatric Respiratory Disease Therapeutics Market Share by Region (2019-2030)
Figure 39. China Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Japan Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. South Korea Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Southeast Asia Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. India Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Australia Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Latin America Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Latin America Pediatric Respiratory Disease Therapeutics Market Share by Country (2019-2030)
Figure 47. Mexico Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Brazil Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Pediatric Respiratory Disease Therapeutics Market Share by Country (2019-2030)
Figure 51. Turkey Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 53. Novartis AG Revenue Growth Rate in Pediatric Respiratory Disease Therapeutics Business (2019-2024)
Figure 54. Bayer AG Revenue Growth Rate in Pediatric Respiratory Disease Therapeutics Business (2019-2024)
Figure 55. GSK Revenue Growth Rate in Pediatric Respiratory Disease Therapeutics Business (2019-2024)
Figure 56. Merck Revenue Growth Rate in Pediatric Respiratory Disease Therapeutics Business (2019-2024)
Figure 57. Boehringer Ingelheim Revenue Growth Rate in Pediatric Respiratory Disease Therapeutics Business (2019-2024)
Figure 58. Regeneron Pharmaceuticals Revenue Growth Rate in Pediatric Respiratory Disease Therapeutics Business (2019-2024)
Figure 59. AstraZeneca Revenue Growth Rate in Pediatric Respiratory Disease Therapeutics Business (2019-2024)
Figure 60. Roche Revenue Growth Rate in Pediatric Respiratory Disease Therapeutics Business (2019-2024)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
